Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €3.48 EUR
Change Today +0.005 / 0.14%
Volume 0.0
S7Y On Other Exchanges
As of 1:56 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

solazyme inc (S7Y) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/18/14 - €9.04
52 Week Low
02/26/15 - €1.49
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SOLAZYME INC (S7Y)

solazyme inc (S7Y) Related Businessweek News

View More BusinessWeek News

solazyme inc (S7Y) Details

Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blendstocks for marine, motor vehicle, and jet fuels, as well as replacements for petrochemicals, oleochemicals, and functional fluids. It also provides fuels, including SoladieselBD and SoladieselRD for on-road applications; ultra-low sulfur diesel; and Solajet for aviation use. In addition, the company offers microalgae-based food ingredients consisting of Tailored oils and powdered oils; and powdered ingredients comprising AlgaVia whole algal flour, AlgaVia whole algal protein, AlgaVia lipid powder, and encapsulated oils. Additionally, it provides skin and personal care products under the Algenist brand name, which include concentrated reconstructing serum, an anti-aging serum; complete eye renewal balm; firming and lifting cream, an anti-aging moisturizing cream; advanced anti-aging repairing oil, a face oil formulation; and genius cream. The company was incorporated in 2003 and is headquartered in South San Francisco, California.

266 Employees
Last Reported Date: 03/6/15
Founded in 2003

solazyme inc (S7Y) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $560.0K
Chief Financial Officer and Chief Operating O...
Total Annual Compensation: $410.4K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $335.0K
Chief Technology Officer
Total Annual Compensation: $370.8K
Strategic Advisor
Total Annual Compensation: $378.8K
Compensation as of Fiscal Year 2014.

solazyme inc (S7Y) Key Developments

Solazyme and Flotek Industries to Develop & Market New Drilling Fluid Additive

Solazyme and Flotek Industries have signed a joint product development and marketing agreement for a drilling fluid additive that will allow the use of water-based fluids in wells that previously required more expensive oil-based products. The Flocapso additive combines a Flotek fluid with Solazyme's proprietary Encapso lubricant and an associated delivery technology. The companies are currently in an 'active validation project' with a large national oil company in the Middle East and are pursuing commercial applications for Flocapso in both domestic and international markets. In addition, they entered into an alliance under which Solazyme granted Flotek exclusive distribution rights to sell and market Encapso as a drilling fluid lubricant in certain Middle East regions.

Solazyme, Inc. Presents at Morgan Stanley MLP/Diversified Natural Gas, Utilities and Clean Tech Conference, Mar-05-2015

Solazyme, Inc. Presents at Morgan Stanley MLP/Diversified Natural Gas, Utilities and Clean Tech Conference, Mar-05-2015 . Venue: The St. Regis, New York, New York, United States. Speakers: Tyler W. Painter, Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer.

Solazyme, Inc. announced delayed annual 10-K filing

On 03/02/2015, Solazyme, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
S7Y:GR €3.48 EUR +0.005

S7Y Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for S7Y.
View Industry Companies

Industry Analysis


Industry Average

Valuation S7Y Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLAZYME INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at